Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure.

Circulation. Heart Failure
Can M SagL S Maier

Abstract

Transgenic (TG) Ca/calmodulin-dependent protein kinase II (CaMKII)delta(C) mice have heart failure and isoproterenol (ISO)-inducible arrhythmias. We hypothesized that CaMKII contributes to arrhythmias and underlying cellular events and that inhibition of CaMKII reduces cardiac arrhythmogenesis in vitro and in vivo. Under baseline conditions, isolated cardiac myocytes from TG mice showed an increased incidence of early afterdepolarizations compared with wild-type myocytes (P<0.05). CaMKII inhibition (AIP) completely abolished these afterdepolarizations in TG cells (P<0.05). Increasing intracellular Ca stores using ISO (10(-8) M) induced a larger amount of delayed afterdepolarizations and spontaneous action potentials in TG compared with wild-type cells (P<0.05). This seems to be due to an increased sarcoplasmic reticulum (SR) Ca leak because diastolic [Ca](i) rose clearly on ISO in TG but not in wild-type cells (+20+/-5% versus +3+/-4% at 10(-6) M ISO, P<0.05). In parallel, SR Ca leak assessed by spontaneous SR Ca release events showed an increased Ca spark frequency (3.9+/-0.5 versus 2.0+/-0.4 sparks per 100 microm(-1).s(-1), P<0.05). However, CaMKII inhibition (either pharmacologically using KN-93 or genetically using an isofo...Continue Reading

References

Jan 1, 1995·Annual Review of Physiology·A P Braun, H Schulman
Sep 18, 2002·Journal of Molecular and Cellular Cardiology·Lars S Maier, Donald M Bers
Sep 18, 2002·Journal of Molecular and Cellular Cardiology·Jaime DeSantiagoDonald M Bers
Oct 5, 2002·Circulation Research·Thomas R ShannonDonald M Bers
Mar 29, 2005·Nature Medicine·Rong ZhangMark E Anderson
May 30, 2006·Biochemical and Biophysical Research Communications·Lei GaoJohn Marshall
Nov 25, 2006·The Journal of Clinical Investigation·Stefan WagnerLars S Maier
Jan 16, 2007·Cardiovascular Research·Martin Vila-PetroffAlicia Mattiazzi
Jan 16, 2007·Cardiovascular Research·Alicia MattiazziCecilia Mundiña-Weilenmann
Jan 24, 2007·Journal of Molecular and Cellular Cardiology·Sabine Huke, Donald M Bers
Oct 24, 2007·Journal of Molecular and Cellular Cardiology·Can M SagLars S Maier
Jul 16, 2008·Circulation·Christina MauritzUlrich Martin
Oct 1, 2008·Circulation·Derek JuangKim Eagle
Jan 31, 2009·Proceedings of the National Academy of Sciences of the United States of America·Johannes BacksEric N Olson

❮ Previous
Next ❯

Citations

Sep 27, 2013·Basic Research in Cardiology·Can M SagLars S Maier
May 27, 2011·European Journal of Applied Physiology·Guri KaurstadUlrik Wisløff
Aug 31, 2012·Heart Failure Reviews·Thomas H FischerSamuel Sossalla
Jul 7, 2012·Current Heart Failure Reports·Lars S Maier
Jun 7, 2011·Acta Pharmacologica Sinica·Mark D McCauley, Xander H T Wehrens
Dec 17, 2009·Cardiovascular Research·Kathryn H Yuill, Sergey V Smirnov
Feb 15, 2013·Cardiovascular Research·Andriy E BelevychSandor Györke
Jul 12, 2011·Physiological Reviews·Jeffrey R EricksonMark E Anderson
Jun 9, 2012·Circulation Research·Paari Dominic SwaminathanMark E Anderson
Aug 19, 2010·International Heart Journal·Anusak KijtawornratRobert L Hamlin
Jul 25, 2013·Pflügers Archiv : European journal of physiology·Tamara P MartinSusan Currie
Apr 16, 2014·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·H E DriessenM A Vos
Jul 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Torsten ChristAlberto Kaumann
Oct 5, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Xander H T Wehrens
Jun 7, 2013·Basic Research in Cardiology·Stefan Neef, Lars S Maier
Jul 5, 2010·Pharmaceuticals·Naranjan S Dhalla, Alison L Müller
Sep 1, 2014·Journal of Molecular and Cellular Cardiology·Can M SagBernhard Unsöld
Jan 31, 2015·Journal of the American College of Cardiology·Anett Hellebø OttesenHelge Røsjø
May 20, 2014·The American Journal of Cardiology·Ravinea ManotheepanMathis K Stokke
Aug 9, 2011·Journal of Molecular and Cellular Cardiology·Can M SagLars S Maier
Mar 23, 2011·Pharmacology & Therapeutics·Jérôme ThireauSylvain Richard
Mar 1, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Michael GrimmJoan Heller Brown
Feb 1, 2011·Journal of Molecular and Cellular Cardiology·Mark E AndersonDonald M Bers
Jul 27, 2010·Journal of Molecular and Cellular Cardiology·Yasmin L HashambhoyRaimond L Winslow
Apr 20, 2011·Drug Discovery Today. Disease Mechanisms·Howard Schulman, Mark E Anderson
May 4, 2010·Biochemical and Biophysical Research Communications·Jaya Pal Gangopadhyay, Noriaki Ikemoto
Nov 4, 2009·Journal of Molecular and Cellular Cardiology·Michael Grimm, Joan Heller Brown
Mar 19, 2014·Journal of Molecular and Cellular Cardiology·Anne C KöhlerLars S Maier
Jun 19, 2013·Biochimica Et Biophysica Acta·Sameer AtherXander H T Wehrens
Jun 29, 2011·Journal of Molecular and Cellular Cardiology·Jeffrey J Saucerman, Donald M Bers
Jul 23, 2015·Heart Failure Reviews·Lorna DanielsJeffrey R Erickson
Jun 25, 2013·Expert Opinion on Therapeutic Targets·B Daan WestenbrinkJoan Heller Brown
Mar 31, 2015·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Christos TzimasDespina Sanoudou
Oct 9, 2012·Journal of the American College of Cardiology·Gregory OuelletIlan Goldenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.